ArticleEBioMedicine2019

Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway.

Yiyi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.